Autopsy report · NCT02644473

Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients

“Study did not receive IRB approval, so did not start”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Albert Einstein College of Medicine

Sponsor type

University, hospital or other

Conditions

Pulmonary Embolism; Deep Vein Thrombosis; Stroke; Myocardial Infarction

Interventions

Tranexamic Acid; Normal saline

Participants

0

Trials that died the same way

• Study Comparing Intubation Via Video Laryngeal Mask Airways (VLMAs) Versus Video Laryngoscopy
  “Study never approved by the IRB. Was not initiated” (91% match in meaning)
• Suprainguinal Fascia Iliaca Compartment Block in Direct Anterior Approach to Total Hip Arthroplasty
  “Study never approved by IRB or initiated” (89% match in meaning)
• Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
  “Study halted prematurely; IRB approval not obtained” (89% match in meaning)
• Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
  “did not move forward with IRB approval, competing study” (86% match in meaning)
• Adherence to Otezla
  “Terminated IRB approval 6/26/2024, study was never initiated or activated” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.